• myGriffith
    • Staff portal
    • Contact Us⌄
      • Future student enquiries 1800 677 728
      • Current student enquiries 1800 154 055
      • International enquiries +61 7 3735 6425
      • General enquiries 07 3735 7111
      • Online enquiries
      • Staff phonebook
    View Item 
    •   Home
    • Griffith Research Online
    • Reports
    • View Item
    • Home
    • Griffith Research Online
    • Reports
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

  • All of Griffith Research Online
    • Communities & Collections
    • Authors
    • By Issue Date
    • Titles
  • This Collection
    • Authors
    • By Issue Date
    • Titles
  • Statistics

  • Most Popular Items
  • Statistics by Country
  • Most Popular Authors
  • Support

  • Contact us
  • FAQs
  • Admin login

  • Login
  • Systematic Review of Infection Control Literature Relating to Intravascular Devices

    View/Open
    RickardPUB58.pdf (4.522Mb)
    File version
    Version of Record (VoR)
    Author(s)
    Rickard, Claire
    Ray-Barruel, Gillian
    Griffith University Author(s)
    Ray-Barruel, Gillian A.
    Rickard, Claire
    Year published
    2009
    Metadata
    Show full item record
    Abstract
    IVD insertion is the most commonly performed invasive healthcare procedure with approximately 14 million IVDs used in Australia each year (Maki 1992; Australian Bureau of Statistics 2008). Despite their important role in diagnostic and therapeutic care, IVDs are a potential source of healthcare associated infection, the most severe form being IVD-related bloodstream infection (IVD-BSI). About 250,000-500,000 IVD-related BSIs occur each year in the United States alone, and 5,000 cases in Australia. (Collignon 1994; Maki, Kluger et al. 2006; Australian Bureau of Statistics 2008) IVD BSIs are associated with increased mortality, ...
    View more >
    IVD insertion is the most commonly performed invasive healthcare procedure with approximately 14 million IVDs used in Australia each year (Maki 1992; Australian Bureau of Statistics 2008). Despite their important role in diagnostic and therapeutic care, IVDs are a potential source of healthcare associated infection, the most severe form being IVD-related bloodstream infection (IVD-BSI). About 250,000-500,000 IVD-related BSIs occur each year in the United States alone, and 5,000 cases in Australia. (Collignon 1994; Maki, Kluger et al. 2006; Australian Bureau of Statistics 2008) IVD BSIs are associated with increased mortality, and substantially increase hospital stay and treatment costs by up to 20 days, and US$56,000/episode.(Maki, Kluger et al. 2006) To attempt to prevent these complications, clinicians and researchers have built a significant body of literature and practices. Some of have been tested more or less thoroughly, in a variety of devices. Regular updates to guidelines on prevention of infection in intravascular devices have been published since the 1970s, with more recent years seeing a higher emphasis on evidence-based practice, with more careful assessment of the quality and level of evidence provided by research. There are myriad infection prevention strategies used or recommended in IVD care; it was impossible for this report to cover all of them. Instead, 5 of the major areas of concern to everyday practitioners in the most common line types have been reviewed; skin preparation prior to insertion, barrier precautions during insertion, type and frequency of site dressings, replacement intervals for IVDs, and duration of use for administration sets. For more extensive guidelines covering other interventions, the reader is referred to the 2002 Centers for Disease Control and Prevention (CDC) Guidelines, the 2008 Society of Healthcare Epidemiology of America (SHEA), and the 2009 Infectious Diseases Society of American (IDSA) Guidelines. (O'Grady, Alexander et al. 2002; Marschall, Mermel et al. 2008; Mermel, Allon et al. 2009) It is noted, that the CDC Guidelines are now 7 years old (a new version is expected imminently, but would be expected to be consistent with the IDSA Guidelines), and that the SHEA guidelines focus only on central venous devices. In addition, although these Guidelines cover a larger range of evidence and literature than this review, their inclusion and exclusion criteria after the initial literature search are often not explicit, and different methods of critiquing and attributing levels of evidence are used to that described here.
    View less >
    Publisher URI
    https://nhmrc.gov.au
    Copyright Statement
    © The Author(s) 2009. The attached file is reproduced here in accordance with the copyright policy of the publisher. Please refer to the publisher’s website for further information.
    Subject
    Infectious Diseases
    Clinical Nursing: Secondary (Acute Care)
    Publication URI
    http://hdl.handle.net/10072/154248
    Collection
    • Reports

    Footer

    Disclaimer

    • Privacy policy
    • Copyright matters
    • CRICOS Provider - 00233E

    Tagline

    • Gold Coast
    • Logan
    • Brisbane - Queensland, Australia
    First Peoples of Australia
    • Aboriginal
    • Torres Strait Islander